Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer

This publication has 9 references indexed in Scilit:

• Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
  American Journal of Obstetrics and Gynecology, 1991
• Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma
  American Journal of Obstetrics and Gynecology, 1990
• The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines.
  Journal of Clinical Investigation, 1989
• Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma
  American Journal of Obstetrics and Gynecology, 1988
• High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas
  International Journal of Radiation Oncology*Biology*Physics, 1988
• CA 125: A useful marker in endometrial carcinoma
  American Journal of Obstetrics and Gynecology, 1986
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983